InBody Co Ltd
KOSDAQ:041830
Intrinsic Value
InBody Co., Ltd. engages in the manufacture and sale of medical equipment. [ Read More ]
The intrinsic value of one InBody Co Ltd stock under the Base Case scenario is 34 248.8 KRW. Compared to the current market price of 26 700 KRW, InBody Co Ltd is Undervalued by 22%.
Valuation Backtest
InBody Co Ltd
Run backtest to discover the historical profit from buying and selling InBody Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
InBody Co Ltd
Current Assets | 149B |
Cash & Short-Term Investments | 98.9B |
Receivables | 17.5B |
Other Current Assets | 32.6B |
Non-Current Assets | 125.5B |
Long-Term Investments | 30.1B |
PP&E | 85.9B |
Intangibles | 1.2B |
Other Non-Current Assets | 8.2B |
Current Liabilities | 17.5B |
Accounts Payable | 155.8m |
Accrued Liabilities | 3B |
Other Current Liabilities | 14.3B |
Non-Current Liabilities | 8.2B |
Long-Term Debt | 3.6B |
Other Non-Current Liabilities | 4.6B |
Earnings Waterfall
InBody Co Ltd
Revenue
|
170.4B
KRW
|
Cost of Revenue
|
-37.9B
KRW
|
Gross Profit
|
132.5B
KRW
|
Operating Expenses
|
-94.1B
KRW
|
Operating Income
|
38.3B
KRW
|
Other Expenses
|
-1.6B
KRW
|
Net Income
|
36.7B
KRW
|
Free Cash Flow Analysis
InBody Co Ltd
Profitability Score
Profitability Due Diligence
InBody Co Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Score
InBody Co Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
InBody Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
InBody Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
InBody Co Ltd
According to Wall Street analysts, the average 1-year price target for InBody Co Ltd is 37 740 KRW with a low forecast of 37 370 KRW and a high forecast of 38 850 KRW.
Shareholder Return
Price
InBody Co Ltd
Average Annual Return | -0.61% |
Standard Deviation of Annual Returns | 26.39% |
Max Drawdown | -51% |
Market Capitalization | 347.8B KRW |
Shares Outstanding | 13 026 847 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
InBody Co., Ltd. engages in the manufacture and sale of medical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-12-14. The firm mainly produces body composition analyzers under the brand names of InBody and Lookin’Body. The firm mainly produces body composition analyzers under the brand name InBody and Lookin’Body. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include Lookin’Body3.0 and Lookin’Body Basic, which are used for measuring proteins, minerals, fats, moistures and others. The company also provides body mass index (BMI) measuring devices under the brand name of BSM. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one InBody Co Ltd stock under the Base Case scenario is 34 248.8 KRW.
Compared to the current market price of 26 700 KRW, InBody Co Ltd is Undervalued by 22%.